Reference Citation Analysis: Find an Article, Find a Category, Find a Journal, Find a Scholar

For: Beam CF, Schady DA, Rose KL, Kelley W, Rakkhit R, Hornsby CD, Studer-Martinez SL. The Preparation of 4,5-Dihydro-3-Aryl-Naphth-[1,2-c]- Isoxazoles From Dilithiated 1-Tetralone Oxime and Aromatic Esters. SYNTHETIC COMMUN 2000. [DOI: 10.1080/00397910008086979] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]

For:	Beam CF, Schady DA, Rose KL, Kelley W, Rakkhit R, Hornsby CD, Studer-Martinez SL. The Preparation of 4,5-Dihydro-3-Aryl-Naphth-[1,2-c]- Isoxazoles From Dilithiated 1-Tetralone Oxime and Aromatic Esters. SYNTHETIC COMMUN 2000. [DOI: 10.1080/00397910008086979] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]

Number

Cited by Other Article(s)

Xiao HY, Watterson SH, Langevine CM, Srivastava AS, Ko SS, Zhang Y, Cherney RJ, Guo WW, Gilmore JL, Sheppeck JE, Wu DR, Li P, Ramasamy D, Arunachalam P, Mathur A, Taylor TL, Shuster DJ, McIntyre KW, Shen DR, Yarde M, Cvijic ME, Marino AM, Balimane PV, Yang Z, Banas DM, Cornelius G, D’Arienzo CJ, Warrack BM, Lehman-McKeeman L, Salter-Cid LM, Xie J, Barrish JC, Carter PH, Dyckman AJ, Dhar TGM. Identification of Tricyclic Agonists of Sphingosine-1-phosphate Receptor 1 (S1P1) Employing Ligand-Based Drug Design. J Med Chem 2016;59:9837-9854. [DOI: 10.1021/acs.jmedchem.6b01099] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]

Affiliation(s)

Hai-Yun Xiao Research and Development, Bristol-Myers Squibb Company, P.O. Box 4000, Princeton, New Jersey 08543-4000, United States
Scott H. Watterson Research and Development, Bristol-Myers Squibb Company, P.O. Box 4000, Princeton, New Jersey 08543-4000, United States
Charles M. Langevine Research and Development, Bristol-Myers Squibb Company, P.O. Box 4000, Princeton, New Jersey 08543-4000, United States
Anurag S. Srivastava Research and Development, Bristol-Myers Squibb Company, P.O. Box 4000, Princeton, New Jersey 08543-4000, United States
Soo S. Ko Research and Development, Bristol-Myers Squibb Company, P.O. Box 4000, Princeton, New Jersey 08543-4000, United States
Yanlei Zhang Research and Development, Bristol-Myers Squibb Company, P.O. Box 4000, Princeton, New Jersey 08543-4000, United States
Robert J. Cherney Research and Development, Bristol-Myers Squibb Company, P.O. Box 4000, Princeton, New Jersey 08543-4000, United States
Wei-Wei Guo Research and Development, Bristol-Myers Squibb Company, P.O. Box 4000, Princeton, New Jersey 08543-4000, United States
John L. Gilmore Research and Development, Bristol-Myers Squibb Company, P.O. Box 4000, Princeton, New Jersey 08543-4000, United States
James E. Sheppeck Research and Development, Bristol-Myers Squibb Company, P.O. Box 4000, Princeton, New Jersey 08543-4000, United States
Dauh-Rurng Wu Research and Development, Bristol-Myers Squibb Company, P.O. Box 4000, Princeton, New Jersey 08543-4000, United States
Peng Li Research and Development, Bristol-Myers Squibb Company, P.O. Box 4000, Princeton, New Jersey 08543-4000, United States
Duraisamy Ramasamy BMS Biocon Research Center, Bangalore 560099, India
Piramanayagam Arunachalam BMS Biocon Research Center, Bangalore 560099, India
Arvind Mathur Research and Development, Bristol-Myers Squibb Company, P.O. Box 4000, Princeton, New Jersey 08543-4000, United States
Tracy L. Taylor Research and Development, Bristol-Myers Squibb Company, P.O. Box 4000, Princeton, New Jersey 08543-4000, United States
David J. Shuster Research and Development, Bristol-Myers Squibb Company, P.O. Box 4000, Princeton, New Jersey 08543-4000, United States
Kim W. McIntyre Research and Development, Bristol-Myers Squibb Company, P.O. Box 4000, Princeton, New Jersey 08543-4000, United States
Ding-Ren Shen Research and Development, Bristol-Myers Squibb Company, P.O. Box 4000, Princeton, New Jersey 08543-4000, United States
Melissa Yarde Research and Development, Bristol-Myers Squibb Company, P.O. Box 4000, Princeton, New Jersey 08543-4000, United States
Mary Ellen Cvijic Research and Development, Bristol-Myers Squibb Company, P.O. Box 4000, Princeton, New Jersey 08543-4000, United States
Anthony M. Marino Research and Development, Bristol-Myers Squibb Company, P.O. Box 4000, Princeton, New Jersey 08543-4000, United States
Praveen V. Balimane Research and Development, Bristol-Myers Squibb Company, P.O. Box 4000, Princeton, New Jersey 08543-4000, United States
Zheng Yang Research and Development, Bristol-Myers Squibb Company, P.O. Box 4000, Princeton, New Jersey 08543-4000, United States
Dana M. Banas Research and Development, Bristol-Myers Squibb Company, P.O. Box 4000, Princeton, New Jersey 08543-4000, United States
Georgia Cornelius Research and Development, Bristol-Myers Squibb Company, P.O. Box 4000, Princeton, New Jersey 08543-4000, United States
Celia J. D’Arienzo Research and Development, Bristol-Myers Squibb Company, P.O. Box 4000, Princeton, New Jersey 08543-4000, United States
Bethanne M. Warrack Research and Development, Bristol-Myers Squibb Company, P.O. Box 4000, Princeton, New Jersey 08543-4000, United States
Lois Lehman-McKeeman Research and Development, Bristol-Myers Squibb Company, P.O. Box 4000, Princeton, New Jersey 08543-4000, United States
Luisa M. Salter-Cid Research and Development, Bristol-Myers Squibb Company, P.O. Box 4000, Princeton, New Jersey 08543-4000, United States
Jenny Xie Research and Development, Bristol-Myers Squibb Company, P.O. Box 4000, Princeton, New Jersey 08543-4000, United States
Joel C. Barrish Research and Development, Bristol-Myers Squibb Company, P.O. Box 4000, Princeton, New Jersey 08543-4000, United States
Percy H. Carter Research and Development, Bristol-Myers Squibb Company, P.O. Box 4000, Princeton, New Jersey 08543-4000, United States
Alaric J. Dyckman Research and Development, Bristol-Myers Squibb Company, P.O. Box 4000, Princeton, New Jersey 08543-4000, United States
T. G. Murali Dhar Research and Development, Bristol-Myers Squibb Company, P.O. Box 4000, Princeton, New Jersey 08543-4000, United States

Collapse

Vella JH, Patel NS, Meierhoefer MA, Hilton EJ, Sober CL, Grant BJ, Kramp CR, Knight JD, Metz CR, Beam CF, Pennington WT, Vanderveer DG. The preparation of 3,3a,4,5-tetrahydronaphth[1,2-c]isoxazoles from dilithiated 1-tetralone oxime and select aromatic aldehydes. J Heterocycl Chem 2013. [DOI: 10.1002/jhet.5570430210] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]

Hernández-Linares MG, Sandoval-Ramírez J, Meza-Reyes S, Montiel-Smith S, Guerrero-Luna G. Stereospecific synthesis of new steroidal isoxazoles in dry media. Steroids 2011;76:1521-6. [PMID: 21872615 DOI: 10.1016/j.steroids.2011.08.003] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/26/2011] [Revised: 08/11/2011] [Accepted: 08/11/2011] [Indexed: 11/27/2022]

Choi E, Knight JD, Malatanos MD, Rhett JM, Walters MJ, Dunn SP, Beam CF. Preparation of 4,5‐Dihydronaphth[2,1‐c]isoxazoles from Dilithiated 2‐Tetralone Oxime and Select Esters. SYNTHETIC COMMUN 2008. [DOI: 10.1080/00397910701820228] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]